Healthcare IT Today
MARCH 15, 2024
According to BSI’s recent Trust in AI Poll , which surveyed 10,000 adults across nine countries, including the U.S., We’re already seeing the benefits of AI-infused research in pharmaceuticals and drug development. billion by 2032. Fortunately, consumers are largely excited about AI’s potential in this space.
Digital Health Global
JANUARY 31, 2024
In a large, bi-annual survey on patient experiences with clinical research, use of electronic consent forms (on an iPad, tablet, or other device) increased from 24% in 2019 to 44% in 2021, dipping slightly in 2023 to 32%. Medable, which ranked in the top 8% of software companies on the 2023 Inc. in Phase 3.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Health Populi
APRIL 29, 2019
As patients now assume the role of health consumer, they rationally expect retail-level experiences with greater first-dollar payment for health insurance, health care services and medical products like prescription drugs. One in two people said, “like Amazon,” and another 20% of folks said, “like retail.”
Society for Participatory Medicine
JANUARY 27, 2022
Patient engagement is measured by Consumer Assessment of Healthcare Processes and Services (CAHPS) surveys & Patient Activation Measures (PAM). The same definition of patient engagement applies to industry, except that the interventions lead to more human centered design and value-based care.
Healthcare IT Today
FEBRUARY 28, 2020
New healthcare AI and Machine Learning research conducted by Healthcare IT Today suggests that many industry leaders are serious about adopting healthcare AI and machine learning tools and what’s more, that these technologies are being used as part of mission-critical efforts rather than one-off pilot tests.
Digital Health Global
NOVEMBER 30, 2023
Furthermore, by fostering connectivity and automating tasks, DHTs reduce administrative burdens, accelerate recruitment, and improve overall trial transparency, ultimately contributing to faster and more reliable drug development. It has been used in various studies in Europe with great results.
Henry Kotula
MARCH 10, 2021
The majority of healthcare and life sciences executives (82%) want to see their organizations more aggressively adopt AI technology, according to a new survey from KPMG, an audit, tax and advisory services firm. And executives across industries are optimistic about the new administration in Washington, D.C., As the U.S.
Expert insights. Personalized for you.
90 
Let's personalize your content